Newton D, Klee C, Woodgett J, Cohen P
Biochim Biophys Acta. 1985 Jun 30;845(3):533-9. doi: 10.1016/0167-4889(85)90222-8.
Occupancy of one of the two phenothiazine-binding sites on calmodulin does not significantly decrease the affinity of calmodulin for its target proteins; however, it does affect the ability of calmodulin to activate some enzymes. Previously we demonstrated that a covalent adduct of calmodulin with one molecule of phenothiazine (CAPP1-calmodulin) is an antagonist for the calmodulin-dependent enzymes, cAMP phosphodiesterase and myosin kinase, and a partial agonist for calcineurin. We now show that CAPP1-calmodulin is a full agonist for glycogen synthase kinase and phosphorylase kinase. Unlike phenothiazines, CAPP1-calmodulin is specific for calmodulin-regulated proteins; it has no effect on protein kinase C. With the exception of phosphorylase kinase, occupancy of two phenothiazine-binding sites completely eliminates the ability of calmodulin to activate these proteins. Thus, the study of the interaction of CAPP1-calmodulin with calmodulin target proteins demonstrates that calmodulin interacts differently with different proteins. This is confirmed by studies of the effect of calmodulin fragments, 1-77 and 78-148, on calmodulin-regulated enzymes.
钙调蛋白上两个吩噻嗪结合位点之一被占据,并不会显著降低钙调蛋白对其靶蛋白的亲和力;然而,这确实会影响钙调蛋白激活某些酶的能力。此前我们证明,钙调蛋白与一分子吩噻嗪形成的共价加合物(CAPP1 - 钙调蛋白)是钙调蛋白依赖性酶(cAMP磷酸二酯酶和肌球蛋白激酶)的拮抗剂,也是钙调神经磷酸酶的部分激动剂。我们现在表明,CAPP1 - 钙调蛋白是糖原合酶激酶和磷酸化酶激酶的完全激动剂。与吩噻嗪不同,CAPP1 - 钙调蛋白对钙调蛋白调节的蛋白具有特异性;它对蛋白激酶C没有影响。除了磷酸化酶激酶外,两个吩噻嗪结合位点被占据会完全消除钙调蛋白激活这些蛋白的能力。因此,对CAPP1 - 钙调蛋白与钙调蛋白靶蛋白相互作用的研究表明,钙调蛋白与不同蛋白的相互作用方式不同。对钙调蛋白片段1 - 77和78 - 148对钙调蛋白调节酶作用的研究证实了这一点。